Status:

NOT_YET_RECRUITING

Neprilysin Inhibition to Reduce Myocardial Fibrosis in Heart Failure With Preserved Ejection Fraction

Lead Sponsor:

Brigham and Women's Hospital

Conditions:

Heart Failure With Preserved Ejection Fraction

Myocardial Fibrosis

Eligibility:

All Genders

50-85 years

Phase:

PHASE4

Brief Summary

Cardiac magnetic resonance imaging (MRI) measures of myocardial interstitial fibrosis (MIF) are elevated in heart failure with preserved ejection fraction (HFpEF) patients and associated with poor pro...

Eligibility Criteria

Inclusion

  • Adults aged 50 years or older
  • Able to provide informed consent, as assessed by a physician investigator, and willing to comply with the study
  • Clinically confirmed diagnosis of heart failure
  • Left ventricular ejection fraction greater than or equal to 45% within 1 year by echocardiogram, cardiac MRI, or nuclear scan

Exclusion

  • Contraindication to MRI (metal prosthesis, implantable cardiac device, or severe claustrophobia)
  • Systolic blood pressure \< 100mm Hg, or \<110 mm Hg for patients not taking an ACE inhibitor or angiotensin receptor blocker
  • symptomatic hypotension
  • eGFR \< 30 mL/min/1.73m2 within 60 days of enrollment
  • Serum potassium \>5.2mmol/L within 60 days of enrollment, or \>5.0 mmol/L for patients not taking an ACE inhibitor or angiotensin receptor blocker
  • Myocardial infarction within 6 months of enrollment
  • Infiltrative or hypertrophic cardiomyopathy
  • History of cirrhosis, biliary cirrhosis, or cholestasis
  • History of angioedema
  • Pregnancy, planning pregnancy, or breastfeeding
  • Active treatment with lithium or a direct renin inhibitor

Key Trial Info

Start Date :

January 1 2026

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

September 1 2029

Estimated Enrollment :

36 Patients enrolled

Trial Details

Trial ID

NCT06536309

Start Date

January 1 2026

End Date

September 1 2029

Last Update

January 7 2026

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

Neprilysin Inhibition to Reduce Myocardial Fibrosis in Heart Failure With Preserved Ejection Fraction | DecenTrialz